Patent · US Active

Organic compounds

US9556186B2 · kind B2 · utility

12Cited by

34References

27Claims

0Family size

Assignee

INTRA-CELLULAR THERAPIES, INC. · US

Inventors

Peng Li · New York, US
Hailin Zheng · Teaneck, US
Jun Zhao · New York, US
Lawrence P. Wennogle · Fryeburg, US

Key dates

Filing date	Jun 4, 2015
Grant date	Jan 31, 2017
Priority date	—
Expiry date	Jun 4, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are PDE1 inhibitors of Formula I, processes for their production, their use as pharmaceuticals, and pharmaceutical compositions comprising them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.